Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 162-167 , April 2008

Chronic Kidney Disease Risk Reduction in a Hispanic Population Through Pharmacist-Based Disease-State Management

  • Sandra Leal
    • ,
  • Marisa Soto

      Affiliations

    • Corresponding Author InformationAddress correspondence to Marisa Soto, PharmD, CDE, 7490 S. Camino De Oeste, Tucson, AZ 85746.

References 

  1. Intermountain End-Stage Renal Disease Network, Inc: ESRD Network Organization #15: Annual Report 2006. Centers for Medicare & Medicaid Services January 1, 2006-December 31, 2006
  2. American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917–932
  3. Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136:565–574
  4. Maljanian R, Grey N, Staff I, et al. Improved diabetes control through a provider-based disease management program. Dis Manage Health Outcomes. 2002;10:1–8
  5. Norris SL, Nichols PJ, Casperson CJ, et al. The effectiveness of disease and case management for people with diabetes: A systemic review. Am J Prev Med. 2002;22:15–38
  6. Bessman AN. Comparison of medical care in nurse clinician and physician clinics in medical school affiliated hospitals. J Chronic Dis. 1974;27:115–125
  7. Stein GH. The use of a nurse practitioner in the management of patients with diabetes mellitus. Med Care. 1974;12:885–890
  8. Coast-Senior EA, Kroner BA, Kelley CL, et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998;32:636–640
  9. American Diabetes Association: National Diabetes Fact Sheet. Alexandria, VA: ADA; 2003;
  10. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–932
  11. Anderson PO, Taryle DA. Pharmacist management of ambulatory patients using formalized standards of care. Am J Hosp Pharm. 1974;31:254–257
  12. Johnson RE, Tuchler RJ. Role of the pharmacist in primary health care. Am J Hosp Pharm. 1975;32:162–164
  13. Erickson SH. Primary care by a pharmacist in an outpatient clinic. Am J Hosp Pharm. 1977;34:1086–1090
  14. Copeland GP, Apgar DA. The pharmacist practitioner training program. Drug Intell Clin Pharm. 1980;14:114–119
  15. Church RM. Pharmacy practice in the Indian health service. Am J Hosp Pharm. 1987;44:771–775
  16. Herrier RN, Boyce RW, Apgar DA. Pharmacist-managed patient care services and prescriptive authority in the U.S. Public Health Service. Hosp Formul. 1990;25:67–6876-78, 80
  17. Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc. 1998;38:574–585
  18. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001;21:1337–1344
  19. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project impact: hyperlipidemia. J Am Pharm Assoc. 2000;40:157–165
  20. Whellan DJ, Gaulden L, Gattis WA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001;161:2223–2228
  21. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes and health care costs. Arch Int. Med. 1998;158:1641–1647
  22. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2002;21:1196–1203
  23. Kelley C, Rodgers PT. Implementation and evaluation of a pharmacist-managed diabetes service. J Manage Care Pharm. 2000;6:488–493
  24. Nau DP, Blevins JD, Neal SE. Collaborating with community pharmacists to improve the quality of diabetes care in an IPA model HMO. J Manage Care Pharm. 2001;7:292–296
  25. Anon . Collaborative drug therapy agreements lead to improved diabetes management. Formulary. 2001;36:538–539
  26. Yanchick JK. Implementation of drug therapy monitoring clinic in a primary care setting. Am J Health Syst Pharm. 2000;57(suppl 4):S30–S37
  27. Baran RW, Crumlish K, Patterson H, et al. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm. 1999;56:1535–1539
  28. Nau DP, Ponte CD. Effects of community pharmacy-based diabetes patient-management program on intermediate clinical outcome measures. J Manag Care Pharm. 2002;8:48–53
  29. Cranor CW, Christensen DB. The Ashville project: Short-term outcomes of a community pharmacy-based diabetes care program. J Am Pharm Assoc. 2003;43:149–159
  30. Kelley C, Rodgers PT. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm. 2000;6:488–493
  31. Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy. 2005;25:96–109
  32. Knapp KK, Okamota MP, Black BL. ASHP survey of ambulatory care pharmacy practice in health systems: 2004. Am J Health Syst Pharm. 2005;62:274–284
  33. Leal S, Herrier RN, Glover JJ, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004;27:2983–2984
  34. Leichter SB, Faulkner S, Camp J. On the cost of being a diabetic patient: variables for physician prescribing behavior. Clin Diabetes. 2000;18:42–44
  35. Insuring America's Health: Principles and Recommendations. Committee on the Consequences of Uninsurance. Washington, DC: Board on Health Care Services, Institute of Medicine; 2004;pp 1-160

PII: S1548-5595(08)00008-6

doi: 10.1053/j.ackd.2008.01.007

Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 162-167 , April 2008

Article Tools